Literature DB >> 18414448

Prostate cancer and metastasis initiating stem cells.

Kathleen Kelly1, Juan Juan Yin.   

Abstract

Androgen refractory prostate cancer metastasis is a major clinical challenge. Mechanism-based approaches to treating prostate cancer metastasis require an understanding of the developmental origin of the metastasis-initiating cell. Properties of prostate cancer metastases such as plasticity with respect to differentiated phenotype and androgen independence are consistent with the transformation of a prostate epithelial progenitor or stem cell leading to metastasis. This review focuses upon current evidence and concepts addressing the identification and properties of normal prostate stem or progenitor cells and their transformed counterparts.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18414448     DOI： 10.1038/cr.2008.50

Source DB:  PubMed          Journal:  Cell Res        ISSN： 1001-0602            Impact factor:   25.617


  26 in total

1.  Selective inhibitory effect of HPMA copolymer-cyclopamine conjugate on prostate cancer stem cells.

Authors:  Yan Zhou; Jiyuan Yang; Jindřich Kopeček
Journal:  Biomaterials       Date:  2011-12-03       Impact factor: 12.479

2.  Targeting of α(v)-integrins in stem/progenitor cells and supportive microenvironment impairs bone metastasis in human prostate cancer.

Authors:  Geertje van der Horst; Christel van den Hoogen; Jeroen T Buijs; Henry Cheung; Henny Bloys; Rob C M Pelger; Giocondo Lorenzon; Bertrand Heckmann; Jean Feyen; Philippe Pujuguet; Roland Blanque; Philippe Clément-Lacroix; Gabri van der Pluijm
Journal:  Neoplasia       Date:  2011-06       Impact factor: 5.715

3.  miR-24-3p stimulates migration, invasion and proliferation of prostate cancer cells by targeting suppressor of cytokine signaling 6.

Authors:  Yang Lin; Huifang Cao; Yuxin Tian; Xinping Yang; Changdong Zhou; Qifu Zhang
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

4.  Integrin αv expression is required for the acquisition of a metastatic stem/progenitor cell phenotype in human prostate cancer.

Authors:  Christel van den Hoogen; Geertje van der Horst; Henry Cheung; Jeroen T Buijs; Rob C M Pelger; Gabri van der Pluijm
Journal:  Am J Pathol       Date:  2011-09-09       Impact factor: 4.307

5.  Tumorspheres derived from prostate cancer cells possess chemoresistant and cancer stem cell properties.

Authors:  Linlin Zhang; Min Jiao; Lei Li; Dapeng Wu; Kaijie Wu; Xiang Li; Guodong Zhu; Qiang Dang; Xinyang Wang; Jer-Tsong Hsieh; Dalin He
Journal:  J Cancer Res Clin Oncol       Date:  2012-01-12       Impact factor: 4.553

6.  HPMA copolymer-based combination therapy toxic to both prostate cancer stem/progenitor cells and differentiated cells induces durable anti-tumor effects.

Authors:  Yan Zhou; Jiyuan Yang; Johng S Rhim; Jindřich Kopeček
Journal:  J Control Release       Date:  2013-09-14       Impact factor: 9.776

7.  Rapid selection and proliferation of CD133+ cells from cancer cell lines: chemotherapeutic implications.

Authors:  Sarah E Kelly; Altomare Di Benedetto; Adelaide Greco; Candace M Howard; Vincent E Sollars; Donald A Primerano; Jagan V Valluri; Pier Paolo Claudio
Journal:  PLoS One       Date:  2010-04-08       Impact factor: 3.240

8.  Pathway biomarker profiling of localized and metastatic human prostate cancer reveal metastatic and prognostic signatures.

Authors:  Robert L Grubb; Jianghong Deng; Peter A Pinto; James L Mohler; Arul Chinnaiyan; Mark Rubin; W Marston Linehan; Lance A Liotta; Emanuel F Petricoin; Julia D Wulfkuhle
Journal:  J Proteome Res       Date:  2009-06       Impact factor: 4.466

9.  Marker-independent method for isolating slow-dividing cancer stem cells in human glioblastoma.

Authors:  Cristina Richichi; Paola Brescia; Valeria Alberizzi; Lorenzo Fornasari; Giuliana Pelicci
Journal:  Neoplasia       Date:  2013-07       Impact factor: 5.715

10.  Proliferation and apoptotic rates and increased frequency of p63-positive cells in the prostate acinar epithelium of alloxan-induced diabetic rats.

Authors:  Fanny Oliveira Arcolino; Daniele Lisboa Ribeiro; Marina Guimarães Gobbo; Sebastião Roberto Taboga; Rejane Maira Góes
Journal:  Int J Exp Pathol       Date:  2009-12-22       Impact factor: 1.925
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.